Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
External Resources & References Sikiric et al
The typical patient has a soft-tissue injury that stalled: they completed physical therapy, have no surgical indication, but are still symptomatic at 8 to 12 weeks
.jpg)
the individual-compound trials that do exist are small, decades-old, and often in patient (not healthy-adult) populations
For laboratories running parallel studies across multiple compounds, this centralised approach ensures accuracy across the board
Some individuals tolerate GHK-CU well at half the standard dose but experience problems at full doses
10.1186/s12943-020-01258-7 Summary Keywords ulcerative colitis, GHK-Cu, SIRT1/STAT3 pathway, co-culture system, network pharmacology, molecular docking Citation Mao S, Huang J, Li J, Sun F, Zhang Q, Cheng Q, Zeng W, Lei D, Wang S and Yao J (2025) Exploring the beneficial effects of GHK-Cu on an experimental model of colitis and the underlying mechanisms
US$ 29.34
US$ 23.40
US$ 28.94
US$ 25.93
US$ 25.60
